05 Nov 2019 --- Barentz, a Netherlands-based distributor of ingredients in the life science markets, is continuing its acquisition spree with a majority shareholding in Czech Republic-based IMCoPharma, which is active in pharmaceutical ingredients. This move gives Barentz the licensing capability to do business with all pharmaceutical companies in the Commonwealth of Independent States (CIS) region and Ukraine. The deal will bolster IMCoPharma’s position in this market and create new opportunities. The financial details have not been disclosed.
